Evidence map›Paper›PMID 40598365›Full record

ArticleBMC health services research2025

AI-driven healthcare innovations for enhancing clinical services during mass gatherings (Hajj): task force insights and future directions.

Ala'a Alquayt, Ohoud Aljuhani, Abdullah F Alharthi, Rahaf Alqahtani, Anas Khan, Ahmed Al-Jedai, Abdulqader Almoeen, Mohammed Alshennawi, Hisham A Badreldin, Abdulrhman Aljouie and 10 more

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Digital epidemiology investments, Saudi Arabia.Bulletin of the World Health Organization · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ala'a AlquaytClinical Pharmacy Services, Eradah and Mental Health Complex, Ministry of Health (MOH), Riyadh, Saudi Arabia.
Ohoud AljuhaniDepartment of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Abdullah F AlharthiDepartment of Clinical Pharmacy, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Al-Dawadmi, 11961, Saudi Arabia.
Rahaf AlqahtaniPharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Anas KhanDepartment of Emergency Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ahmed Al-JedaiSaudi Society of Clinical Pharmacy, Riyadh, Saudi Arabia.
Abdulqader AlmoeenHealth Sector Transformation Program (HSTP), Riyadh, Saudi Arabia.
Mohammed AlshennawiTherapeutics Deputyship, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, Saudi Arabia.
Hisham A BadreldinPharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Abdulrhman AljouieDepartment of Data Managment , King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0002-5592-2462
Lubna A AlnasserDepartment of Population Health, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.ORCID http://orcid.org/0009-0004-1442-5293
Abdulmajeed M AlshehriPharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Mohammed Y AlzahraniPharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Haifa A AlhaidalCollege of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Raghad AlhajajiMakkah Branch of Ministry of Health, Saudi Ministry of Health, Makkah, Saudi Arabia.
Salman AlotaibiHead of pharmacy, King Faisal Complex for Ministry Health, Taif, Saudi Arabia.
Esraa Z RedhwanMedical Laboratory Sciences Department-MLS Program, Fakeeh College for Medical Sciences, Jeddah, 21461, Saudi Arabia.
Fahad AlharthiDepartment of Pharmacy, King Abdulaziz Hospital, Makkah, Saudi Arabia.
Badr G AlghamdiTherapeutics Deputyship, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, Saudi Arabia.
Khalid Al SulaimanPharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia. alsulaimankh@mngha.med.sa.ORCID http://orcid.org/0000-0002-5547-2043

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the high complexity of healthcare during mass gatherings (MG), the integration of Artificial Intelligence (AI) might be crucial. AI can enhance healthcare delivery, improve patient care, optimize resources, and ensure efficient management of the large-scale healthcare demands during Hajj. This paper aims to provide an overview of AI utilization specifically during Hajj and explore the potential role of AI-driven tools in healthcare and clinical services provided to pilgrims.

methodsA task force was formed and included experts healthcare providers, AI specialists, and members from the Saudi Society for Multidisciplinary Research Development and Education (SCAPE Society), Saudi Critical Care Pharmacy Research (SCAPE) platform, Saudi Society of Clinical Pharmacy (SSCP), policymakers, and frontline healthcare practitioners involved in Hajj. The task force first agreed on the framework and voting system, then organized into teams to draft content for specific domains. Consensus was reached using a voting system requiring over 80% agreement, and all task force members reviewed and finalized the drafts. The selection of AI specialists, policymakers, and frontline healthcare practitioners for the task force was based on their expertise and relevance to healthcare during Hajj.

resultsThe task force identified key focus areas: (1) Patient Care: AI tools for predictive analytics, triage, resource management, and virtual healthcare. (2) Healthcare Providers: AI in medical imaging, care delivery, provider-patient communication, and training. (3) Operational Management: AI for healthcare documentation and reducing administrative burden. (4) Healthcare Systems: AI for early detection and automation during Hajj. The task force constructed ten statements to guide future initiatives.

conclusionExpanding the role of AI in healthcare during MGs will help optimize healthcare outcomes and utilization. Concerns about AI ethics and data security need to be addressed. Additional data is needed to address the gaps in the literature regarding AI's applicability in healthcare services during MGs.

Indexed as

Artificial IntelligenceDelivery of Health CareIslamMass GatheringsAdvisory CommitteesCOVID-19HumansSaudi ArabiaArtificial intelligence (AI)HajjHealthcareMass gatherings (MGs)Predictive analytics

Identifiers

PMID40598365
PMCPMC12220523

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.